HBM joins Allena syndicate in $25M series B

Allena Pharmaceuticals Inc. (Newton, Mass.) raised $25 million in a series B financing led by HBM Partners. Existing investors Frazier Healthcare; Third Rock Ventures; Bessemer Venture Partners; and new investor Pharmstandard International participated. HBM's Axel Bolte joined Allena's board. Allena did not disclose whether the financing was tranched. ...